Following administration of a combined oral contraceptive (0.035 mg ethinyl estradiol and 0.25 mg norgestimate) in the presence of a single dose of tirzepatide 5 mg, mean Cmax of ethinyl estradiol, norgestimate, and norelgestromin was reduced by 59%,66%, and 55%, while mean AUC was reduced by 20%, 21%, and 23%, respectively
Watch for redness that spreads, warmth, pus, fever, or a streak moving away from the injection spot
At LifeRx.md, we guide patients to track progress beyond the mirror
34:e23318
BPC-157 and TB-500 are also listed by WADA under category S0 (Unapproved Substances) and are prohibited in tested sport
Double the payoff, no added steps